TP53 and neoplasm: AMPK, as a metabolic regulator, has recognized to be a tumor suppressor, due to its involvement in multiple networks, including LKB1, TSC1-TSC2 complex, and P53 (Thirupathi and Chang, 2019; Ma et al., 2020).